EUVIMEDEUVIMED entdecken
Open Access

Electronic Consent at US Cancer Centers: A Survey of Practices, Challenges, and Opportunities

Susan Chimonas iD, Allison Lipitz-Snyderman iD, Kemi Gaffney, Gilad J Kuperman iD

JCO Clinical Cancer Informatics · 2023

DOI: 10.1200/cci.22.00122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2023. Verfasst von Susan Chimonas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. Hauptthemen laut MEDLINE: Telemedicine, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Digital technologies create opportunities for improving consenting processes in cancer care and research. Yet, little is known about the prevalence of electronic consenting, or e-consent, at US cancer care institutions. METHODS We surveyed institutions in the National Comprehensive Cancer Network about their capabilities for clinical, research, and administrative e-consents; technologies used; telemedicine consents; multilingual support; evaluations; and opportunities and challenges in moving from paper-based to electronic processes. Responses were summarized across responding institutions. RESULTS Twenty-five institutions completed the survey (81% response rate). Respondents were from all census regions and included freestanding and matrix cancer centers. Twenty (80%) had e-consent capabilities, with variability in the extent of adoption: One (5%) had implemented e-consent for all clinical, research, and administrative needs while 19 (95%) had a mix of paper and electronic consenting. Among those with e-consent capabilities, the majority (14 of 20, 70%) were using features embedded in their electronic health record. Most had a combination of paper and e-consenting for clinical purposes (18, 72%). About two-thirds relied entirely on paper for research consents (16, 64%) but had at least some electronic processes for administrative consents (15, 60%). Obstacles to e-consenting included challenges with procuring or maintaining hardware, content management, workflow integration, and digital literacy of patients. Successes included positive user experiences, workflow improvements, and better record-keeping. Only two of 20 (10%) respondents with e-consent capabilities had evaluated the impact of automating consent processes. CONCLUSION E-consent was prevalent in our sample, with 80% of institutions reporting at least some capabilities. Further progress is needed for the benefits of e-consenting to be realized broadly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineNeoplasmsHumansInformed ConsentSurveys and QuestionnairesElectronic Health RecordsElectronics

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Digital Informatics and Technology Solutions, Memorial Sloan Kettering Cancer Center, New York, NY.

ORCID-Profile: Susan Chimonas, Allison Lipitz-Snyderman, Gilad J Kuperman

Förderung

  • NCI NIH HHS

Zitieren

APA

Chimonas, S., Lipitz-Snyderman, A., Gaffney, K., & Kuperman, G. J. (2023). Electronic Consent at US Cancer Centers: A Survey of Practices, Challenges, and Opportunities. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.22.00122

Vancouver

Chimonas S, Lipitz-Snyderman A, Gaffney K, Kuperman GJ. Electronic Consent at US Cancer Centers: A Survey of Practices, Challenges, and Opportunities. JCO Clinical Cancer Informatics. 2023. doi:10.1200/cci.22.00122

BibTeX
@article{Chimonas2023,
  author = {Chimonas, Susan and Lipitz-Snyderman, Allison and Gaffney, Kemi and Kuperman, Gilad J},
  title = {Electronic Consent at US Cancer Centers: A Survey of Practices, Challenges, and Opportunities},
  journal = {JCO Clinical Cancer Informatics},
  year = {2023},
  doi = {10.1200/cci.22.00122}
}
Kostenlos starten →